NMRA |
Neumora Therapeutics, Inc. |
Oct 17, 2024 |
12 |
-$244K |
4 |
Oct 18, 2024 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Jun 18, 2024 |
2 |
$0 |
4 |
Jun 20, 2024 |
Director |
NMRA |
Neumora Therapeutics, Inc. |
Jun 13, 2024 |
2 |
$0 |
4 |
Jun 14, 2024 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jun 7, 2024 |
2 |
$0 |
4 |
Jun 11, 2024 |
Director |
ATRA |
Atara Biotherapeutics, Inc. |
Mar 31, 2024 |
1 |
$0 |
4 |
Apr 2, 2024 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Mar 20, 2024 |
12 |
-$1.39M |
4 |
Mar 22, 2024 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Mar 7, 2024 |
3 |
-$620K |
4 |
Mar 11, 2024 |
Director |
NMRA |
Neumora Therapeutics, Inc. |
Sep 14, 2023 |
1 |
$0 |
4 |
Sep 18, 2023 |
Director |
NMRA |
Neumora Therapeutics, Inc. |
Sep 14, 2023 |
0 |
$0 |
3 |
Sep 14, 2023 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jun 16, 2023 |
2 |
$0 |
4 |
Jun 21, 2023 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Jun 7, 2023 |
3 |
-$171K |
4 |
Jun 9, 2023 |
Director |
ATRA |
Atara Biotherapeutics, Inc. |
May 31, 2023 |
2 |
$0 |
4 |
Jun 2, 2023 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jul 13, 2022 |
3 |
-$111K |
4 |
Jul 15, 2022 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Jun 24, 2022 |
2 |
$0 |
4 |
Jun 28, 2022 |
Director |
ATRA |
Atara Biotherapeutics, Inc. |
Jun 23, 2022 |
2 |
$0 |
4 |
Jun 27, 2022 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jun 17, 2022 |
1 |
$0 |
4 |
Jun 21, 2022 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Mar 4, 2022 |
2 |
$303K |
4 |
Mar 8, 2022 |
Director |
ATRA |
Atara Biotherapeutics, Inc. |
Nov 4, 2021 |
1 |
-$260K |
4 |
Nov 5, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Nov 1, 2021 |
3 |
-$211K |
4 |
Nov 3, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Sep 8, 2021 |
3 |
-$143K |
4 |
Sep 9, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jul 26, 2021 |
3 |
-$88.4K |
4 |
Jul 27, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jul 19, 2021 |
3 |
-$88K |
4 |
Jul 20, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jul 12, 2021 |
3 |
-$94K |
4 |
Jul 13, 2021 |
Director |
RARE |
Ultragenyx Pharmaceutical Inc. |
Jun 24, 2021 |
2 |
$0 |
4 |
Jun 28, 2021 |
Director |
CRNX |
Crinetics Pharmaceuticals, Inc. |
Jun 22, 2021 |
1 |
$0 |
4 |
Jun 23, 2021 |
Director |
ATRA |
Atara Biotherapeutics, Inc. |
Jun 8, 2021 |
2 |
$0 |
4 |
Jun 9, 2021 |
Director |